Indivior PLC (OTCMKTS:INVVY – Get Free Report) passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares traded.
Indivior Stock Performance
The stock’s 50 day moving average price is $21.85 and its 200 day moving average price is $21.85. The company has a market capitalization of $3.01 billion, a P/E ratio of 20.81 and a beta of 0.35.
Indivior Company Profile
Indivior plc is a specialty pharmaceutical company focused on developing and commercializing medicines for substance use disorders and other behavioral health conditions. Its portfolio includes treatments for opioid use disorder, opioid overdose, alcohol use disorder and schizophrenia.
The company’s products include Sublocade, an extended-release buprenorphine injection for opioid use disorder; Suboxone, a buprenorphine and naloxone treatment available in film and tablet formulations; and Opvee, a nalmefene nasal spray designed to reverse opioid overdose.
Featured Stories
- Five stocks we like better than Indivior
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}
